Published in Int J Nanomedicine on May 27, 2016
Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor. Int J Nanomedicine (2017) 0.75
Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci Rep (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol (2001) 6.30
The crystal structure of the human hepatitis B virus capsid. Mol Cell (1999) 4.36
Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol (1990) 4.16
HBV core particles as a carrier for B cell/T cell epitopes. Intervirology (2001) 1.76
TGF-β signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev (2012) 1.67
Targeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammation. Clin Exp Allergy (2012) 1.45
Progress on new vaccine strategies against chronic viral infections. J Clin Invest (2004) 1.38
Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin Biol Ther (2008) 1.24
Therapeutic cancer vaccines. J Clin Invest (2015) 1.23
Induction of epithelial-mesenchymal transition by transforming growth factor β. Semin Cancer Biol (2012) 1.21
Interaction of the hepatitis B core antigen and the innate immune system. J Immunol (2009) 1.05
Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res (2012) 1.04
Interferon gamma signaling alters the function of T helper type 1 cells. J Exp Med (2000) 1.02
A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors. Cancer Gene Ther (2012) 0.97
A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice. PLoS One (2013) 0.92
Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein. Int J Cancer (2012) 0.90
Different spectra of therapeutic vaccine development against HPV infections. Hum Vaccin (2009) 0.90
Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am J Respir Crit Care Med (2007) 0.89
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem (2014) 0.89
Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors. Clin Cancer Res (2009) 0.88
Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X. J Immunol (2014) 0.88
Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice. Am J Respir Cell Mol Biol (2013) 0.87
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity. J Control Release (2013) 0.87
Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation. Hum Vaccin Immunother (2014) 0.85
Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis. Vaccine (2009) 0.84
Chitosan as an adjuvant-like substrate for dendritic cell culture to enhance antitumor effects. Biomaterials (2014) 0.80